PBE vs SCHD
Invesco Biotechnology and Genome ETF vs Schwab US Dividend Equity ETF
Quick Verdict
SCHD has a lower expense ratio. PBE delivered stronger 1-year returns. SCHD offers more diversification with 100 holdings.
Side-by-Side Comparison
| Metric | PBE | SCHD | Winner |
|---|---|---|---|
| Expense Ratio | 0.58% | 0.06% | |
| AUM | $283M | $103.7B | |
| Dividend Yield | 1.73% | 3.31% | |
| Holdings | 33 | 104 | |
| YTD Return | +15.19% | +25.33% | |
| 1Y Return | +47.27% | +32.31% | |
| 3Y Return (annualized) | +15.54% | +15.40% | |
| 5Y Return (annualized) | +4.86% | +9.70% | |
| Volatility (annualized) | 21.2% | 13.6% | |
| Max Drawdown | -45.7% | -33.4% | |
| Fund Family | Invesco (US) | Charles Schwab Asset Management | |
| Category | Equity | Equity | |
| Inception | Jun 23, 2005 | Oct 20, 2011 |
PBE vs SCHD Performance
Invesco Biotechnology and Genome ETF (PBE) is a ETF from Invesco (US) and Schwab US Dividend Equity ETF (SCHD) is a ETF from Charles Schwab Asset Management. Over the past year PBE returned +47.27% while SCHD returned +32.31%. Year to date, PBE is up 15.19% versus a gain of 25.33% for SCHD.
Over three years, PBE compounded at +15.54% per year against +15.40% for SCHD; over five years the annualized figures are +4.86% and +9.70% respectively. Across the full 15-year window we track, SCHD has the edge at +11.45% annualized vs +9.27%. Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
PBE has been the more volatile fund, with annualized monthly volatility of 21.2% compared with 13.6% for SCHD. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -45.7% for PBE and -33.4% for SCHD. Drawdown depth is worth weighing if you expect to sell during market stress rather than ride it out.
The two funds' monthly returns correlate at 0.53. They move independently enough that combining them can meaningfully diversify a portfolio.
Fees and Cost Over Time
PBE charges 0.58% per year while SCHD charges 0.06%. On a $10,000 position that is $58 vs $6 annually, a gap of $52 per year that compounds over a long holding period. On income, PBE currently yields 1.73% against 3.31% for SCHD.
Holdings Overlap
PBE and SCHD share 1 holdings out of 130 unique holdings combined, representing a 4.3% weight overlap.
Moderate overlap means holding both could provide meaningful diversification benefits.
Top Shared Holdings
| Stock | Weight in PBE | Weight in SCHD | Difference |
|---|---|---|---|
| AMGN | 4.86% | 4.25% | 0.61% |
Frequently Asked Questions
Which is cheaper, PBE or SCHD?
PBE has an expense ratio of 0.58% while SCHD charges 0.06%. SCHD is the cheaper option. On a $10,000 investment, that is $52 per year of difference.
Which performed better, PBE or SCHD?
Over the past year PBE returned +47.27% vs +32.31% for SCHD, so PBE leads on 1-year performance. Over the longest common window we track (15 years), PBE annualized +9.27% vs +11.45% for SCHD. Past performance does not guarantee future results.
Which is riskier, PBE or SCHD?
PBE has been the more volatile fund at 21.2% annualized versus 13.6% for SCHD. Worst drawdown: PBE -45.7% vs SCHD -33.4%.
Should I hold both PBE and SCHD?
PBE and SCHD have a monthly-return correlation of 0.53, so combining them can provide real diversification depending on your allocation goals.
What is the holdings overlap between PBE and SCHD?
PBE and SCHD share 1 common holdings with a 4.3% weight overlap. Combined, they hold 130 unique securities.
Which pays a higher dividend, PBE or SCHD?
PBE yields 1.73% while SCHD yields 3.31%, so SCHD currently pays the higher dividend yield.
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.